May 9 (Reuters) - Adicet Bio Inc ACET.O :
* ADICET REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATES
* ADICET BIO-ON TRACK TO REPORT ADDITIONAL
EFFICACY,DURABILITY &
SAFETY DATA, PROVIDE REGULATORY UPDATE AND PLAN FOR ADI-001
PIVOTAL PROGRAM IN 2Q 2023
* CASH AND CASH EQUIVALENTS WERE $231.6 MILLION AS OF MARCH
31,
2023
* EXPECTS CURRENT CASH AND CASH EQUIVALENTS AS OF MARCH 31,
2023,
WILL BE SUFFICIENT TO FUND OPERATING EXPENSES INTO FIRST HALF OF
2025
* QTRLY LOSS PER SHARE $0.72
* Q1 EARNINGS PER SHARE VIEW $-0.69 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw7xVcywa
Further company coverage: ACET.O
((Reuters.Briefs@thomsonreuters.com;))